Back
Monte Rosa Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
Monte Rosa Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.32 | Buy |
| 20-day SMA: | 8.67 | Sell |
| 50-day SMA: | 6.71 | Buy |
| 200-day SMA: | 5.63 | Buy |
| 8-day EMA: | 8.37 | Sell |
| 20-day EMA: | 8.13 | Buy |
| 50-day EMA: | 7.13 | Buy |
| 200-day EMA: | 5.88 | Buy |
Monte Rosa Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.48 | Buy |
| Relative Strength Index (14 RSI): | 54.85 | Buy |
| Chaikin Money Flow: | -376551 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.29 - 9.65) | Buy |
| Bollinger Bands (100): | (4.1 - 7.48) | Buy |
Monte Rosa Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monte Rosa Therapeutics Stock
Is Monte Rosa Therapeutics Stock a Buy?
- Monte Rosa Therapeutics share price is 8.35 while GLUE 8-day simple moving average is 8.32, which is a Buy signal.
- The stock price of GLUE is 8.35 while Monte Rosa Therapeutics 20-day SMA is 8.67, which makes it a Sell.
- Monte Rosa Therapeutics 50-day simple moving average is 6.71 while GLUE share price is 8.35, making it a Buy technically.
- GLUE stock price is 8.35 and Monte Rosa Therapeutics 200-day simple moving average is 5.63, creating a Buy signal.
GLUE Technical Analysis vs Fundamental Analysis
Buy
53
Monte Rosa Therapeutics (GLUE)
is a Buy
Is Monte Rosa Therapeutics a Buy or a Sell?
-
Monte Rosa Therapeutics stock is rated a Buy
The current Monte Rosa Therapeutics [GLUE] share price is $8.35. The Score for GLUE is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Monte Rosa Therapeutics Stock Info
Market Cap:
513M
Price in USD:
8.35
Share Volume:
742.93K
Monte Rosa Therapeutics 52-Week Range
52-Week High:
12.40
52-Week Low:
2.91
Buy
53
Monte Rosa Therapeutics (GLUE)
is a Buy
Monte Rosa Therapeutics Share Price Forecast
-
What is the Monte Rosa Therapeutics stock price today?
The Monte Rosa Therapeutics stock price is 8.35 USD today. -
Will GLUE stock go up or go down?
Monte Rosa Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Monte Rosa Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monte Rosa Therapeutics is not overvalued.
Is Monte Rosa Therapeutics Stock a Buy?
- Monte Rosa Therapeutics share price is 8.35 while GLUE 8-day exponential moving average is 8.37, which is a Sell signal.
- The stock price of GLUE is 8.35 while Monte Rosa Therapeutics 20-day EMA is 8.13, which makes it a Buy.
- Monte Rosa Therapeutics 50-day exponential moving average is 7.13 while GLUE share price is 8.35, making it a Buy technically.
- GLUE stock price is 8.35 and Monte Rosa Therapeutics 200-day simple moving average is 5.88, creating a Buy signal.
Fundamental Analysis of Monte Rosa Therapeutics
Is Monte Rosa Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Technical Analysis of Monte Rosa Therapeutics
Should I short Monte Rosa Therapeutics stock?
- GLUE Moving Average Covergence Divergence (MACD) indicator is 0.48, suggesting Monte Rosa Therapeutics is a Buy
- Monte Rosa Therapeutics Relative Strength Index (RSI) is 54.85, which suggest Monte Rosa Therapeutics is overbought
- The Bollinger Bands (25) for Monte Rosa Therapeutics is (6.29 - 9.65), which suggest Monte Rosa Therapeutics is a Buy
- The Bollinger Bands (100) for Monte Rosa Therapeutics is (4.1 - 7.48), which suggest Monte Rosa Therapeutics is a Buy
* Monte Rosa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.